phenylethyl alcohol has been researched along with ADDH in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahl, J; Bangs, M; Liu, P; Nery, ESM; Perahia, D | 1 |
| Allen, AJ; Gruener, D; Jin, L; Kielbasa, W; Krefetz, D; Tauscher-Wisniewski, S; Xu, W | 1 |
| Allen, AJ; D'Souza, DN; Jin, L; Kielbasa, W; Kratochvil, CJ; Lin, DY; Xu, W | 1 |
| Brinda, BJ; Markowitz, JS | 1 |
| Fallgatter, AJ; Gerlach, M; Jacob, C; Kreiker, S; Maisch, A; Romanos, M; Schecklmann, M; Schenk, E; Warnke, A | 1 |
| Allen, AJ; Dean, RA; Jin, L; Kielbasa, W; Lachno, DR; Quinlan, T; Xu, W | 1 |
1 review(s) available for phenylethyl alcohol and ADDH
| Article | Year |
|---|---|
A pharmacokinetic evaluation of oral edivoxetine hydrochloride for the treatment of attention deficit-hyperactivity disorder.
Topics: Administration, Oral; Adolescent; Adrenergic Uptake Inhibitors; Adult; Age Factors; Animals; Attention Deficit Disorder with Hyperactivity; Child; Half-Life; Humans; Kidney Diseases; Liver Diseases; Morpholines; Phenylethyl Alcohol | 2014 |
4 trial(s) available for phenylethyl alcohol and ADDH
| Article | Year |
|---|---|
Long-Term, Open-Label, Safety Study of Edivoxetine Monotherapy in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Attention Deficit Disorder with Hyperactivity; Child; Dose-Response Relationship, Drug; Female; Humans; Longitudinal Studies; Male; Morpholines; Norepinephrine; Phenylethyl Alcohol; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome | 2017 |
Clinical outcomes from an open-label study of edivoxetine use in pediatric patients with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Child; Female; Heart Rate; Humans; Male; Morpholines; Phenylethyl Alcohol; Psychiatric Status Rating Scales; Suicidal Ideation; Treatment Outcome | 2013 |
A randomized trial of edivoxetine in pediatric patients with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Methylphenidate; Morpholines; Phenylethyl Alcohol; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 2014 |
Pharmacokinetics and pharmacodynamics of edivoxetine (LY2216684), a norepinephrine reuptake inhibitor, in pediatric patients with attention-deficit/hyperactivity disorder.
Topics: Administration, Oral; Adolescent; Adrenergic Uptake Inhibitors; Age Factors; Area Under Curve; Attention Deficit Disorder with Hyperactivity; Child; Chromatography, Liquid; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Male; Morpholines; Phenylethyl Alcohol; Tandem Mass Spectrometry; Tissue Distribution | 2012 |
1 other study(ies) available for phenylethyl alcohol and ADDH
| Article | Year |
|---|---|
Altered frontal and temporal brain function during olfactory stimulation in adult attention-deficit/hyperactivity disorder.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Brain Mapping; Frontal Lobe; Humans; Magnetic Resonance Imaging; Male; Olfactory Perception; Phenylethyl Alcohol; Psychiatric Status Rating Scales; Smell; Spectroscopy, Near-Infrared; Surveys and Questionnaires; Temporal Lobe | 2011 |